Paper42865622PubMed
FDX1 is associated with CALR abundance and JAK-STAT-related inflammatory signaling in myeloproliferative neoplasms.
Abuduaini D and 4 others. Front Oncol, 2026.
Cite this record
ConductScience Library. FDX1 is associated with CALR abundance and JAK-STAT-related inflammatory signaling in myeloproliferative neoplasms. Papers, record 42865622. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42865622
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- FDX1 is associated with CALR abundance and JAK-STAT-related inflammatory signaling in myeloproliferative neoplasms.
- Journal
- Front Oncol
- Year
- 2026
- Publication types
- Journal Article
- Revised in PubMed
- 2026-10-14
Source PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References31
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34390367 | Early and late stage MPN patients show distinct gene expression profiles in CD34+ cells. | Ann Hematol | 2021 | https://conductscience.org/library/papers/34390367 | PubMed |
| 2 | 20427518 | ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking. | Bioinformatics | 2010 | https://conductscience.org/library/papers/20427518 | PubMed |
| 3 | 22455463 | clusterProfiler: an R package for comparing biological themes among gene clusters. | OMICS | 2012 | https://conductscience.org/library/papers/22455463 | PubMed |
| 4 | 25822800 | Robust enumeration of cell subsets from tissue expression profiles. | Nat Methods | 2015 | https://conductscience.org/library/papers/25822800 | PubMed |
| 5 | 22375971 | A double-blind, placebo-controlled trial of ruxolitinib for myelofibrosis. | N Engl J Med | 2012 | https://conductscience.org/library/papers/22375971 | PubMed |
| 6 | 33597522 | Inference and analysis of cell-cell communication using CellChat. | Nat Commun | 2021 | https://conductscience.org/library/papers/33597522 | PubMed |
| 7 | 26951227 | Mutant Calreticulin Requires Both Its Mutant C-terminus and the Thrombopoietin Receptor for Oncogenic Transformation. | Cancer Discov | 2016 | https://conductscience.org/library/papers/26951227 | PubMed |
| 8 | 24325359 | Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2. | N Engl J Med | 2013 | https://conductscience.org/library/papers/24325359 | PubMed |
| 9 | 39383242 | A proinflammatory stem cell niche drives myelofibrosis through a targetable galectin-1 axis. | Sci Transl Med | 2024 | https://conductscience.org/library/papers/39383242 | PubMed |
| 10 | 26668133 | Thrombopoietin receptor activation by myeloproliferative neoplasm associated calreticulin mutants. | Blood | 2016 | https://conductscience.org/library/papers/26668133 | PubMed |
| 11 | 35298263 | Copper induces cell death by targeting lipoylated TCA cycle proteins. | Science | 2022 | https://conductscience.org/library/papers/35298263 | PubMed |
| 12 | 32386542 | Single-Cell Analyses Reveal Megakaryocyte-Biased Hematopoiesis in Myelofibrosis and Identify Mutant Clone-Specific Targets. | Mol Cell | 2020 | https://conductscience.org/library/papers/32386542 | PubMed |
| 13 | 31270458 | Somatic mutations and cell identity linked by Genotyping of Transcriptomes. | Nature | 2019 | https://conductscience.org/library/papers/31270458 | PubMed |
| 14 | 15781101 | Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. | Lancet | 2005 | https://conductscience.org/library/papers/15781101 | PubMed |
| 15 | 26854026 | Myeloproliferative neoplasms and inflammation: whether to target the malignant clone or the inflammatory process or both. | Leukemia | 2016 | https://conductscience.org/library/papers/26854026 | PubMed |
| 16 | 15793561 | A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. | Nature | 2005 | https://conductscience.org/library/papers/15793561 | PubMed |
| 17 | 20808728 | Regularization Paths for Generalized Linear Models via Coordinate Descent. | J Stat Softw | 2010 | https://conductscience.org/library/papers/20808728 | PubMed |
| 18 | 21300928 | Circulating interleukin (IL)-8, IL-2R, IL-12, and IL-15 levels are independently prognostic in primary myelofibrosis: a comprehensive cytokine profiling study. | J Clin Oncol | 2011 | https://conductscience.org/library/papers/21300928 | PubMed |
| 19 | 35732831 | The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms. | Leukemia | 2022 | https://conductscience.org/library/papers/35732831 | PubMed |
| 20 | 34062119 | Integrated analysis of multimodal single-cell data. | Cell | 2021 | https://conductscience.org/library/papers/34062119 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42865622
GET https://conductscience.org/api/papers/v1/42865622/references?page=2